iShares Biotechnology ETF
317 hedge funds and large institutions have $5.3B invested in iShares Biotechnology ETF in 2014 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 96 increasing their positions, 117 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 117
22% less call options, than puts
Call options by funds: $461M | Put options by funds: $594M
Holders
317
Holding in Top 10
17
Calls
$461M
Puts
$594M
Top Buyers
| 1 | +$291M | |
| 2 | +$127M | |
| 3 | +$123M | |
| 4 |
Morgan Stanley
New York
|
+$30.4M |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$30.4M |
Top Sellers
| 1 | -$66.1M | |
| 2 | -$44.2M | |
| 3 | -$19.5M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15.2M |
| 5 |
EAM
Eclectica Asset Management
London,
United Kingdom
|
-$14.9M |